MEDICIS PHARMACEUTICAL CORPORATION

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 68187
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 4749
 
  
 
C07D HETEROCYCLIC COMPOUNDS 28134
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 4150
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 445
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 2138
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 268
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 1239
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1106
 
  
 
A61Q USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS 158

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2014/0274,970 Controlled Release Pharmaceutical Dosage FormsMay 08, 13Sep 18, 14[A61K]
2014/0274,982 TOPICAL COMPOSITIONS OF FLUNISOLIDE AND METHODS OF TREATMENTMar 14, 14Sep 18, 14[A61K]
2012/0238,913 METHODS OF EVALUATING NORMALCY OF LIPS AND SAFETY OF LIP TREATMENTSMar 15, 12Sep 20, 12[A61B, A61M]
2011/0319,811 COMBINATION THERAPY WITH CRYOSURGERY AND LOW DOSAGE STRENGTH IMIQUIMOD TO TREAT ACTINIC KERATOSISJun 24, 11Dec 29, 11[A61M]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9642998 Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod creamMar 06, 15May 09, 17[A61K, B05B, A61M]
9561241 Gastroretentive dosage forms for minocyclineJun 28, 12Feb 07, 17[A61K, A01N]
9492682 Combination therapy with low dosage strength imiquimod and photodynamic therapy to treat actinic keratosisSep 14, 12Nov 15, 16[A61K, A61Q, A61N]
9370509 2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimodAug 06, 12Jun 21, 16[A61K]
9271973 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapyNov 27, 13Mar 01, 16[A61K]
9192615 Method for the treatment of acne and certain dosage forms thereofAug 05, 09Nov 24, 15[A61K]
9119793 Gastroretentive dosage forms for doxycyclineJun 28, 12Sep 01, 15[A61K]
9078889 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal wartsNov 27, 13Jul 14, 15[A61K, A01N]
9072876 Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod creamSep 03, 10Jul 07, 15[A61K, B05B, G01F, A61M]
8946274 Methods of improving skin qualitySep 10, 12Feb 03, 15[A61K, A01N, A61Q]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0206,735 HIGH DOSAGE TOPICAL METRONIDAZOLE AQUEOUS-BASED GEL FORMULATIONS AND THEIR USE TO TREAT ROSACEAAbandonedDec 20, 13Jul 24, 14[A61K]
2012/0329,823 LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORT DOSING REGIMENS FOR TREATING GENITAL AND PERIANAL WARTSAbandonedJun 26, 12Dec 27, 12[A61K, A61P]
2012/0329,824 LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORT DOSING REGIMENS FOR TREATING GENITAL AND PERIANAL WARTSAbandonedJul 26, 12Dec 27, 12[A61K, A61P]
2012/0329,825 LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORT DOSING REGIMENS FOR TREATING GENITAL AND PERIANAL WARTSAbandonedJul 26, 12Dec 27, 12[A61K, A61P]
2012/0329,835 USE OF 1-HYDROXY-2- PYRIDONES FOR THE TREATMENT OF SEBORRHEIC DERMATITISAbandonedJul 23, 12Dec 27, 12[A61K, A61P]
2012/0289,490 COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTEROID DELIVERYAbandonedJul 30, 12Nov 15, 12[A61K, A61P]
2012/0289,537 METHODS OF TREATING DERMATOLOGICAL DISORDERS AND INDUCING INTERFERON BIOSYNTHESIS WITH SHORTER DURATIONS OF IMIQUIMOD THERAPYAbandonedJul 18, 12Nov 15, 12[A61K, A61P]
2012/0264,778 METHODS OF TREATING DERMATOLOGICAL DISORDERS AND INDUCING INTERFERON BIOSYNTHESIS WITH SHORTER DURATIONS OF IMIQUIMOD THERAPYAbandonedJun 26, 12Oct 18, 12[A61K, A61P]
8263097 Methods and compositions for treating acneExpiredDec 22, 11Sep 11, 12[A61K, A61L]
8242155 Method of treating actinic keratosis with 3.75% imiquimod creamWithdrawnJul 13, 11Aug 14, 12[A01N]
2012/0115,954 Aqueous retinoid and benzoyl peroxide gelAbandonedJan 18, 12May 10, 12[A61K, A61P]
2012/0093,892 MINOCYCLINE ORAL DOSAGE FORMS FOR THE TREATMENT OF ACNEAbandonedDec 21, 11Apr 19, 12[A61K, A61P]
2012/0083,507 METHODS OF TREATING DERMATOLOGICAL DISORDERS AND INDUCING INTERFERON BIOSYNTHESIS WITH SHORTER DURATIONS OF IMIQUIMOD THERAPYAbandonedDec 08, 11Apr 05, 12[A61K, A61P]
2012/0046,576 Mid-face aesthetic scale and related methodsAbandonedAug 19, 11Feb 23, 12[A61B]
2011/0263,633 UP TO SIX WEEKS TREATMENT REGIMEN FOR TREATING ACTINIC KERATOSES WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMODAbandonedJul 08, 11Oct 27, 11[A61K, A61P]
2011/0263,634 LOWER DOSAGE STRENGTH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMODAbandonedJul 08, 11Oct 27, 11[A61K, A61P]
2011/0263,636 3 x 3 x 3 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75 % IMIQUIMODAbandonedJul 17, 11Oct 27, 11[A61K, A61P]
2011/0263,637 UP TO SIX WEEKS DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75% IMIQUIMODAbandonedJul 18, 11Oct 27, 11[A61K, A61P]
2011/0257,217 3 x 3 x 3 WEEK TREATMENT REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMODAbandonedJul 08, 11Oct 20, 11[A61K, A61P]
2011/0257,219 LOWER DOSAGE STRENGTH PHARMACEUTICAL COMPOSITIONS FORUMLATED WITH 3.75% IMIQUIMODAbandonedJul 12, 11Oct 20, 11[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.